Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04617912 · ClinicalTrials.gov registry record · NA
PennPET Explorer Scanner Evaluation
A NA study of Healthy and Cognitive Impairment, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 268
- Enrollment target
- 1
- Study location
NCT04617912: Active NA study of Healthy and Cognitive Impairment, sponsored by University of Pennsylvania.
NCT04617912 is a NA study of Healthy and Cognitive Impairment that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 268 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04617912, a NA study of Healthy and Cognitive Impairment, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 268 participants
- Enrollment target
- 1
- Study location
Study Summary
Positron Emission Tomography (PET) is a procedure that uses a special type of machine to take pictures of the inside of the body after a radioactive drug is administered. The radioactive drug that is used for this study may be an FDA approved imaging drug or may be used as an investigational imaging drug as part of another study for which participants are taking part. PET using various radiotracers is useful for the diagnosis of various diseases, including cancer, brain diseases, infection, and heart or lung disease. The purpose of this study is to test a research PET machine called the PennPET Explorer long-axial field-of-view scanner. This research PET machine can image a larger section of the body than the current clinical PET scanners, allowing most of the body to be imaged at one time. This scanner is still an investigational device and is being tested in this study to collect more information about how best to use this type of whole body scanner.
Primary Outcome
Noise behavior, structural detail and local contrast will be combined to report overall image quality using a numerical scale (1 = poor image quality, 5 = superior image quality).
Conditions Studied
Interventions
- DEVICE Long AFOV PennPET Explorer
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2020-11-12 |
| Est. Completion | 2027-01-22 |
| Phase | NA |
What the registry record for NCT04617912 still lists
NCT04617912 is an interventional study that assigns participants to a tested intervention. The registered 268 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Long AFOV PennPET Explorer is the first listed.
NCT04617912 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04617912 about?
NCT04617912 is a clinical study titled "PennPET Explorer Scanner Evaluation". Positron Emission Tomography (PET) is a procedure that uses a special type of machine to take pictures of the inside of the body after a radioactive drug is administered. The radioactive drug that is used for this study may be an FDA approved imaging drug or may be used as an investigational imaging...
What is the current status of trial NCT04617912?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 268 participants. The study started on 2020-11-12. Estimated completion is 2027-01-22.
What conditions does trial NCT04617912 study?
This clinical trial studies the following conditions: Healthy, Cognitive Impairment.
What interventions are being tested in trial NCT04617912?
The interventions under investigation include: Long AFOV PennPET Explorer (DEVICE).
Who is sponsoring clinical trial NCT04617912?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04617912 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04617912's enrollment target sits among peer trials
268 93rd of 1090 higher than 998 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
- NCT05797831 · 268 participants · Phase 2
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- NCT05997381 · 268 participants · NA
BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears
- NCT06233461 · 268 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI